Race Oncology welcomes positive pre-IND meeting for Zantrene

EQS-News: Race Oncology Ltd
Race Oncology welcomes positive pre-IND meeting for Zantrene

24.11.2022 / 17:20 CET/CEST
The issuer is solely responsible for the content of this announcement.

---

---

24.11.2022 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.eqs-news.com

---

Language:	English
Company:	Race Oncology Ltd
	United States
ISIN:	AU000000RAC3
EQS News ID:	1496749

End of News	EQS News Service

---

1496749  24.11.2022 CET/CEST